GHK-Cu Side Effects: Topical vs Injected, and the Copper Question
Research Analysis · 8 min read · Updated October 2026 Short answer: GHK-Cu is two products wearing one name. On
Research Guides
TB-500 Side Effects: What the Human Trials Show (and the Question Nobody Has Answered)
Research Analysis · 9 min read · Updated October 2026 Short answer: the natural protein TB-500 is modelled on, thymosin
BPC-157 Side Effects: What the Research Actually Shows (and the Gap Nobody Mentions)
BPC-157 has a clean animal safety record and almost no human safety data. What 30 years of studies show, what the reported side effects mean, and the measurable risk that has nothing to do with the molecule.
Is Retatrutide Approved Yet? FDA and Health Canada Timeline (October 2026 Update)
Retatrutide is not approved anywhere yet. Lilly plans to file with the FDA in Q1 2027, and it is not on Health Canada’s review list. Here is the realistic timeline, and why approval and availability are not the same in Canada.
Is Retatrutide Safe? What 4,000 Trial Participants Actually Show (and What Nobody Knows Yet)
Retatrutide side effects by dose, the two new safety signals (dysesthesia and heart rate), class risks, muscle loss and the open long-term questions, from every published trial through 2026.
Before You Buy Retatrutide in Canada: 10 Costly Mistakes Almost Everyone Makes
Most retatrutide mistakes happen before the vial is opened: misreading the 28% headline, trusting a recycled COA, paying for 10 mg and getting 6. Here are the 10 we see most, and how to avoid each one.
Retatrutide vs Tirzepatide vs Semaglutide: What the Phase 3 Data Actually Shows (2026)
One receptor, two, three. How semaglutide, tirzepatide and retatrutide differ, what STEP, SURMOUNT and the May 2026 TRIUMPH-1 readout actually measured, and why the numbers are not apples to apples.
Peptides 101: The Plain-English Guide to Research Peptides
What a peptide is, why scientists study them, how research peptides are made and tested, the jargon decoded, and five questions to ask before buying from anyone.
Copper Peptides and Hair: What the GHK-Cu and AHK-Cu Research Really Shows
Copper peptides have decades of hair follicle research behind them, but thin human data. What the GHK-Cu and AHK-Cu studies found, and whether the “better than minoxidil” claim holds up.
Does BPC-157 Cause Cancer? What the Evidence Actually Says
No study shows BPC-157 causes cancer, and no long-term human data proves it does not. Where the angiogenesis concern comes from, and what toxicology studies reported.